Logo image
Back
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid
Journal article   Peer reviewed

Synergistic and additive killing by antimicrobial factors found in human airway surface liquid

Pradeep K Singh, Brian F Tack, Paul B McCray and Michael J Welsh
American journal of physiology. Lung cellular and molecular physiology, Vol.279(5), pp.L799-L805
11/01/2000
DOI: 10.1152/ajplung.2000.279.5.L799
PMID: 11053013

View Online

Abstract

Airway surface liquid contains multiple factors thought to provide a first line of defense against bacteria deposited in the airways. Although the antimicrobial action of individual factors has been studied, less is known about how they work in combination. We examined the combined action of six antimicrobial peptides found in airway surface liquid. The paired combinations of lysozyme-lactoferrin, lysozyme-secretory leukocyte protease inhibitor (SLPI), and lactoferrin-SLPI were synergistic. The triple combination of lysozyme, lactoferrin, and SLPI showed even greater synergy. Other combinations involving the human β-defensins, LL-37, and tobramycin (often administered to cystic fibrosis patients by inhalation) were additive. Because the airway surface liquid salt concentration may be elevated in cystic fibrosis patients, we examined the effect of salt on the synergistic combinations. As the ionic strength increased, synergistic interactions were lost. Our data suggest that the antibacterial potency of airway surface liquid may be significantly increased by synergistic and additive interactions between antimicrobial factors. These results also suggest that increased salt concentrations that may exist in cystic fibrosis could inhibit airway defenses by diminishing these synergistic interactions.

Details

Metrics

15 Record Views
270 Times Cited - Web of Science
Logo image